Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-Gate AGSTU:BIG 30 Quick Ratio is 1.60 as of Dec. 2025, which is 11% below its 10-year median of 1.80. GuruFocus rates STU:BIG with a GF Score™ of 30/100. The stock has 7 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Bio-Gate AG ranks worse than 57.39% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Bio-Gate AG's quick ratio for the quarter that ended in Dec. 2025 was 1.60.
Bio-Gate AG has a quick ratio of 1.60. It generally indicates good short-term financial strength.
The historical rank and industry rank for Bio-Gate AG's Quick Ratio or its related term are showing as below:
STU:BIG'
s Quick Ratio Range Over the Past 10 Years
Min: 0.6 Med: 1.8 Max: 3.62
Current: 1.6
During the past 13 years, Bio-Gate AG's highest Quick Ratio was 3.62. The lowest was 0.60. And the median was 1.80.
STU:BIG's Quick Ratio is ranked worse than 57.39% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs STU:BIG: 1.60
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Bio-Gate AG Quick Ratio Related Terms
Bio-Gate AG Quick Ratio Historical Data
* Premium members only.
The historical data trend for Bio-Gate AG's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:BIG vs ISRG, BDX, MDLN: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Gate AG Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Bio-Gate AG's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Bio-Gate AG's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Gate AG (STU:BIG) has a Quick Ratio of 1.60 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio-Gate AG and its competitors. This is 11% below median its historical median of 1.80. Over the past decade, Bio-Gate AG's Quick Ratio has ranged from 0.60 to 3.62. According to the industry distribution chart, Bio-Gate AG ranks #489 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 57.4%.
Is Bio-Gate AG's Quick Ratio too high?
Bio-Gate AG's current Quick Ratio of 1.60 is 11% below median its 10-year median of 1.80. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 3.62. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Bio-Gate AG's value of 1.60 is 15.3% below this industry median. Based on the distribution chart, Bio-Gate AG ranks #489 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio-Gate AG has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Gate AG's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio-Gate AG ranks #489 out of 852 companies for Quick Ratio. This places Bio-Gate AG in the lower half of its industry. The industry median Quick Ratio is 1.89. Bio-Gate AG's value of 1.60 is 15.3% below this benchmark. Historically, Bio-Gate AG's own Quick Ratio has ranged from 0.60 to 3.62 over the past decade. While the company's 10-year median is 1.80 vs. the industry median of 1.89, Bio-Gate AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Gate AG's current Quick Ratio of 1.60 is 15.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio-Gate AG and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Gate AG's current Quick Ratio is 1.60, which is 11% below median its own 10-year median of 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gate AG stock overvalued right now?
Bio-Gate AG (STU:BIG) has a current Quick Ratio of 1.60. The current Quick Ratio is 1.60, which is 11% below median its 10-year median of 1.80 and 15.3% below the Medical Devices & Instruments industry median of 1.89. Bio-Gate AG's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bio-Gate AG (STU:BIG), the current Quick Ratio is 1.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
30GF Score
Get the complete analysis for STU:BIG
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BIG has been successfully added to your 
